Blimp1-deficient Tfr cells exhibit impaired inhibitory activity and reduced production of Foxp3, CTLA-4, and other cytokines, contributing to inhibit interactions with Tfh cells and B cells and promote anti-tumor immunity, and these destabilized Tfr cells convert to Tfh-like cells [62, 63]. This evidence concerns the gene TFRC and neoplasm.